Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Amicus provides update on second phase III study of migalastat for Fabry disease

July 2, 2014

IND application submitted for ProHema in inherited metabolic disorders

July 2, 2014

Boehringer Ingelheim discloses novel GPR40 agonists

July 2, 2014

EMA committee recommends approval of Abasria

June 30, 2014

FDA approves inhaled insulin for type 1 diabetes

June 30, 2014

Sanofi K.K. announces new alliance

June 30, 2014

RedHill Biopharma reports preclinical data for RHB-104 in type 1 diabetes

June 30, 2014

High-throughput screening for novel GPR103 antagonists as anorexigenics

June 30, 2014

Nora Therapeutics begins phase II study of NT-100 in women with recurrent pregnancy loss

June 27, 2014

BioMarin Pharmaceutical discloses new fusion protein for LSD

June 27, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...